PetMed Express appointed Jeffrey Allen Willard as Chief Executive Officer and President, effective September 28, 2026, succeeding Interim CEO Leslie C.G. Campbell. The Board approved the appointment on August 27, 2026. Mr. Willard receives a $550,000 annual base salary, a $120,000 signing bonus, and equity grants including 250,000 restricted stock shares and up to 250,000 performance stock units. Ms. Campbell resigned from the Board and as Interim CEO due to retirement plans effective on Mr. Willard's start date. The Board elected Justin Mennen as Independent Chair of the Board, eliminating the Lead Independent Director position. PetMed Express operates in the direct-to-consumer pet healthcare sector, offering pharmaceuticals and supplements through its online pharmacy brands.
